EUVIMEDEUVIMED entdecken
Metaanalyse

Efficacy and safety of mepolizumab in patients with severe eosinophilic asthma: a meta-analysis [Retraction]

Xiaoyan Meng

International Journal of Clinical and Experimental Medicine · 2024

DOI: 10.62347/btko8113 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift International Journal of Clinical and Experimental Medicine, 2024. Verfasst von Xiaoyan Meng.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Meng, X. (2024). Efficacy and safety of mepolizumab in patients with severe eosinophilic asthma: a meta-analysis [Retraction]. International Journal of Clinical and Experimental Medicine. https://doi.org/10.62347/btko8113

Vancouver

Meng X. Efficacy and safety of mepolizumab in patients with severe eosinophilic asthma: a meta-analysis [Retraction]. International Journal of Clinical and Experimental Medicine. 2024. doi:10.62347/btko8113

BibTeX
@article{Meng2024,
  author = {Meng, Xiaoyan},
  title = {Efficacy and safety of mepolizumab in patients with severe eosinophilic asthma: a meta-analysis [Retraction]},
  journal = {International Journal of Clinical and Experimental Medicine},
  year = {2024},
  doi = {10.62347/btko8113}
}
Kostenlos starten →